Aqr Capital Management LLC Genprex, Inc. Transaction History

Aqr Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.11 - $4.87 $101,945 - $159,638	-32,780 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.66 - $7.67 $195,063 - $408,780	-53,296 Reduced 61.92%	32,780 $141,000
Q4 2020 Feb 16, 2021	BUY	$3.03 - $5.51 $48,707 - $88,573	16,075 Added 22.96%	86,076 $357,000
Q3 2020 Nov 16, 2020	BUY	$2.9 - $4.29 $203,002 - $300,304	70,001 New	70,001 $235,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.